Metabolon, Inc., a world leader in metabolomics-based diagnostic tests and research services, announced today that it has raised $15 million in a Series E financing through the issuance of preferred stock. New investor Camden Partners led ...
Tags: Metabolon, Series E financing, Camden Partners, financing